https://www.nytimes.com/live/2021/02/22/world/covid-19-coronavirus/the-fda-tells-companies-that-vaccines-adapted-for-new-variants-wont-need-lengthy-clinical-trials
In a story appearing on the New York Times website today by Noah Weiland, Katie Thomas and Carl Zimmer with the headline "The F.D.A. tells companies that vaccines adapted for new variants won’t need lengthy clinical trials" the following sentence appears:
"Despite the recent indications that some variants — and particularly B.1.351 — make the currently authorized vaccines less effective, the shots still offer protection and appear to greatly reduce the severity of the disease, preventing hospitalizations and death."
|
